Livforsakringsbolaget Skandia Omsesidigt lowered its stake in shares of Aetna Inc (NYSE:AET) by 22.2% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 25,896 shares of the company’s stock after selling 7,400 shares during the period. Livforsakringsbolaget Skandia Omsesidigt’s holdings in Aetna were worth $5,253,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds also recently added to or reduced their stakes in AET. Palo Capital Inc. purchased a new stake in shares of Aetna during the third quarter worth $122,000. Kaizen Advisory LLC grew its stake in Aetna by 143.9% during the 2nd quarter. Kaizen Advisory LLC now owns 766 shares of the company’s stock valued at $141,000 after acquiring an additional 452 shares in the last quarter. CSat Investment Advisory L.P. purchased a new stake in Aetna during the 2nd quarter valued at about $162,000. Mainstay Capital Management LLC ADV grew its stake in Aetna by 1,696.3% during the 2nd quarter. Mainstay Capital Management LLC ADV now owns 11,209 shares of the company’s stock valued at $162,000 after acquiring an additional 10,585 shares in the last quarter. Finally, Sun Life Financial INC grew its stake in Aetna by 252.0% during the 2nd quarter. Sun Life Financial INC now owns 887 shares of the company’s stock valued at $163,000 after acquiring an additional 635 shares in the last quarter. 83.49% of the stock is owned by institutional investors and hedge funds.
AET has been the subject of several research reports. Zacks Investment Research raised shares of Aetna from a “hold” rating to a “buy” rating and set a $228.00 price objective for the company in a research note on Thursday, October 4th. Credit Suisse Group upped their price target on Aetna from $202.00 to $207.00 and gave the company a “neutral” rating in a research report on Monday. Finally, Cantor Fitzgerald lowered Aetna from an “overweight” rating to a “neutral” rating and set a $202.00 price target for the company. in a research report on Wednesday, August 22nd. Eight analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Aetna currently has an average rating of “Hold” and an average target price of $204.77.
Aetna (NYSE:AET) last posted its quarterly earnings results on Thursday, August 2nd. The company reported $3.43 earnings per share for the quarter, beating the consensus estimate of $3.04 by $0.39. Aetna had a net margin of 5.77% and a return on equity of 20.66%. The business had revenue of $15.56 billion during the quarter, compared to analysts’ expectations of $15.59 billion. During the same quarter in the prior year, the company posted $3.42 EPS. The business’s revenue for the quarter was up .2% on a year-over-year basis. Equities research analysts predict that Aetna Inc will post 11.3 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Thursday, November 1st. Stockholders of record on Wednesday, October 24th will be paid a $0.50 dividend. The ex-dividend date is Tuesday, October 23rd. This represents a $2.00 annualized dividend and a dividend yield of 1.02%. Aetna’s dividend payout ratio (DPR) is 20.28%.
Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.
Recommended Story: Asset Allocation and Your Retirement
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.